Nerve growth factor levels in parkinson disease and experimental parkinsonian rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nerve growth factor levels in parkinson disease and experimental parkinsonian rats

Published:2002-10 Issue:1 Volume:952 Page:122-127
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Lorigados Pedre Lourdes,Pavón Fuentes Nancy,Alvarez González Lázaro,McRae Amanda,Serrano Sánchez Teresa,Blanco Lescano Lissette,Macı́as González Raúl

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference39 articles.

1. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream;Aloe;Proc. Natl. Acad. Sci. USA,1986

2. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes;Aloe;Proc. Natl. Acad. Sci. USA,1994

3. Haloperidol administration in humans lowers plasma nerve growth factor level: evidence that sedation induces opposite effects to arousal;Aloe;Neuropsychobiology,1997

4. Altered plasma levels of nerve growth factor and transforming growth factor-beta 2 in type-1 diabetes mellitus;Azar;Brain Behav. Immun.,1999

5. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma;Bonini;Proc. Natl. Acad. Sci. USA,1996

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ginsenoside Rg3 Restores Mitochondrial Cardiolipin Homeostasis via GRB2 to Prevent Parkinson's Disease;Advanced Science;2024-08-19

2. Unraveling the AKT/ERK cascade and its role in Parkinson disease;Archives of Toxicology;2024-08-13

3. Small Particles, Big Potential: Polymeric Nanoparticles for Drug Delivery in Parkinson's Disease;Movement Disorders;2024-07-30

4. BDNF- and VEGF-Responsive Stimulus to an NGF Mimic Cyclic Peptide with Copper Ionophore Capability and Ctr1/CCS-Driven Signaling;ACS Chemical Neuroscience;2024-04-11

5. Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease;Frontiers in Neuroendocrinology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3